期刊文献+

受体阻滞剂联合用药及单用治疗膀胱过度活动症合并膀胱出口梗阻的效果比较 被引量:4

Comparison between combined administration of receptor blockers and single administration of receptor blocker in the treatment of patients with overactive bladder syndrome and bladder outlet obstruction
下载PDF
导出
摘要 目的比较α受体阻滞剂联合用药及单用治疗膀胱过度活动症合并膀胱出口梗阻的疗效。方法选取100例膀胱过度活动症合并膀胱出口梗阻患者,随机分为2组。对照组患者采用α受体阻滞剂进行治疗,研究组患者采用α受体阻滞剂联合M受体阻滞剂的治疗方式,比较2组治疗效果。结果研究组患者治疗后的疼痛评分、排尿评分、总积分显著低于对照组患者(P<0.05)。对照组患者治疗后OABSS评分为(7.2±1.5)分,研究组患者治疗后OABSS评分为(4.8±1.2)分,差异有统计学意义(P<0.05)。研究组患者并发症发生率为4.0%,显著低于对照组患者的10.0%(P<0.05)。结论在膀胱过度活动症合并膀胱出口梗阻患者的临床治疗中,受体阻滞剂联合用药具有更好的治疗效果。 Objective To compare the efficacy of combined administration of receptor blockers and single administration of receptor blocker in the treatment of patients with overactive bladder syndrome and bladder outlet obstruction. Methods A total of 100 patients with overactive bladder syndrome and bladder outlet obstruction were randomly divided into two groups. Control group was treated with α receptor blocker,while study group was treated with α receptor blocker and M receptor blocker. Therapeutic effect was compared. Results The pain score,urinary score and total score of the study group were significantly lower than those of the control group( P〈0. 05). After treatment,OABSS score in the control group was( 7. 2 ± 1. 5),which was significantly higher than( 4. 8 ± 1. 2)in the study group( P〈0. 05). The incidence rate of complications in the study group was 4%,which was significantly lower than 10. 0% in the control group( P〈0. 05). Conclusion In the clinical treatment of patients with bladder outlet obstruction,the combination of receptor blockers has a better therapeutic effect.
出处 《实用临床医药杂志》 CAS 2017年第1期59-61,共3页 Journal of Clinical Medicine in Practice
关键词 Α受体阻滞剂 膀胱过度活动症 膀胱出口梗阻 M受体阻滞剂 α receptor blocker overactive bladder syndrome bladder outlet obstruction M receptor blocker
  • 相关文献

参考文献10

二级参考文献126

  • 1沈柏华,金晓东,蔡松良,陈军,陈戈明,赵伟平,孙欣.α1受体阻滞剂联合抗生素治疗慢性前列腺炎疗效及机制[J].中华男科学杂志,2004,10(7):518-520. 被引量:57
  • 2肖河,李汉忠,杨勇,黄钟明,李永强,赵晓峰.M-受体与α-受体阻滞剂联合用药治疗良性前列腺增生及下尿路症状的临床观察[J].中华医学杂志,2007,87(23):1590-1593. 被引量:6
  • 3Abrams P, Cardozo L, Fall M, et al. The standardisation of terminolo- gy in lower urinary tract function: report from the standardisation sub- committee of the International Continence Society [ J ]. Neurourol Uro- dyn, 2002, 21(2) : 167 -178.
  • 4Nowara A, Witek A, Wilk K. Diagnostic and treatment of overactivebladder[J]. Ginekol Pol, 2007, 78(7): 549 -553.
  • 5Wang Y, Xu K, Hu H, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China [ J ]. Neur- ourol Urodyn, 2011, 30(8): 1448-1455.
  • 6Flisser A J, Blaivas J G. Role of eystometry in evaluating patients with overactive bladder[J]. Urology, 2002, 60(5 Suppl 1 ) : 33 -42.
  • 7Digesu G A, Khullar V, Cardozo L, et al. Overactive bladder symp- toms: do we need urodynamics? [J]. Neurourol Urodyn, 2003, 22 (2) : 105 -108.
  • 8Robinson D, Cardozo L. Overactive bladder: diagnosis and manage- ment[J]. Maturitas, 2012, 71(2): 188-193.
  • 9Stahl M M, Ekstrom B, Sparf B, et al. Urodynamie and other effects of tolterodine: a novel antimusearinic drug for the treatment of detrusor overaetivity[J]. Neurourol Urodyn, 1995, 14(6):647-655.
  • 10Haylen B T, de-Ridder D, Freeman R M, et al. An International Urn- gynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction [ J ]. Neurourol Urodyn, 2010, 29 ( 1 ) : 4 - 20.

共引文献79

同被引文献48

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部